Skip to main content
. 2020 Oct 31;10(1):109–118. doi: 10.1002/cam4.3575

Figure 1.

Figure 1

Study Design. Abbreviations: BID, twice daily; HGOC, high‐grade ovarian cancer; RP2D, recommended phase 2 dose